[Sheng Ta] February 2026 Monthly Revenue NT$466 Million (YoY -16.4%)
NQ Score
63/100
N1 Content Completeness
8
AI Summary (NQ-processed)
Sheng Ta (1720) released its financial report, showing that its February 2026 monthly revenue was NT$466 million, a 16.4% decrease compared to the same period last year. As a pharmaceutical company in the biotechnology and healthcare industry, its revenue performance may be affected by drug shipment schedules and market demand.
AI analysis data is not yet available.